The ‘Great Resignation’ Is Finally Getting Companies to Take Burnout Seriously. Is It Enough?
Toward the end of last year, Anthony Klotz, a professor of business administration at Texas A&M University who studies workplace resignations, realized that a lot of people were about to quit their jobs. A record 42.1 million Americans quit a job in 2019, according to U.S. Bureau of Labor Statistics data, but that rate dropped off during the pandemic-addled year of 2020. As 2021 approached, bringing with it the promise of effective vaccines and a return to semi-normal life, Klotz guessed that two things would happen. First, many of the people who wanted to quit in 2020 but held off due to fear or uncertainty would finally feel secure enough to do so. And second, pandemic-era epiphanies, exhaustion and burnout would drive a whole new cohort of people to quit their jobs. In a moment of inspiration, Klotz predicted that a “Great Resignation” was coming. [time-brightcove not-tgx=”true”] It’s safe to say it’s here. Every month from April to August 2021, at least 2.5% of the American workforce quit their jobs. In August alone, more than 4.2 million people handed in their two weeks’ notice, according to federal statistics. So far, 2021 quit levels are about 10% to 15% higher than they were in record-setting 2019, by Klotz’s calculations. Read more: Why Literally Millions of Americans Are Quitting Their Jobs Companies are clearly taking notice, particularly given the staffing shortages that are hamstringing many customer-facing industri...
Dysfunctional breathing, hypocapnia, and myalgic encephalomyelitis/chronic fatigue syndrome were seen in symptomatic patients post-acute COVID-19 despite normal chest imaging and pulmonary function.Medscape Medical News
Two days after the first case of the new Omicron Covid-19 variant was officially confirmed in Massachusetts, the head of the state's largest hospital system stressed the importance of vaccines and masks.
Two years into the pandemic, what's next?
President Biden emphasized how the bill would lower prescription drug costs, an issue his administration hopes will build support for the broader package.
Prioritizing workforce well-being is a key driver of business success. The COVID-19 pandemic changed the world more than any event in recent history, significantly impacting the health and well-being of our workforce and economy. The inextricable link between individual health and productivity, business performance and economic prosperity is clear, and now is the time for employers to actively engage and support the mental and physical health of employees. In a recent survey by The Economist Intelligence…
Dr F Perry Wilson reviews new data about post-mRNA vaccine myocarditis: who is affected, severity, treatment, and outcomes.Medscape
Hello, I am currently a sophomore pre-veterinary student and I am struggling. I did pretty well for my first year of undergrad last year finishing with a 3.57 GPA. This semester has been a different story however. In the first month of school I had an unexpected surgical procedure and I went into a big depression after. Long story short, I had to withdraw from my organic chemistry class and I am possibly going to fail two classes (philosophy and a communications class). In addition, I am... Read more
Chris EdwardsThe main weapons against COVID-19 are the vaccines developed by Moderna and BioNTech after a decade of their research into mRNA technologies. That research was supported by more than $3 billion of private angel investment and venture capital.Democrats and Republicans both support medical research funding, and Republicans tout the Trump administration ’s Operation Warp Speed. But governments were not the key to mRNA development. Instead, we can thank the leaders and scientists at Moderna and BioNTech and the suppliers of private capital to them, as I discusshere andhere.TheWall Street Journal &r...
Fueled by new evidence that wildfire smoke can carry living microbes and is associated with a local increase in COVID-19 cases, scientists wonder if smoke might spread infectious diseases and worsen their effects
Jeffrey A. SingerPolitical polarization hinders progress against the COVID-19 pandemic.Political polarization may explain why, after former President Trump called the off ‐label use of the anti‐malarial drug hydroxychloroquine a “game‐changer” in the battle against COVID-19 (randomized controlled trials found that isnot the case), public health officials and the mainstream press appear uninterested in the off ‐label use of any other drugs as therapeutics against a COVID infection.For example, impressive data from randomized controlled trials show the off ‐label use of the off‐...
More News: Anxiety | Burns | Cardiology | Children | COVID-19 | Depression | Diabetes | Diabetes Type 2 | Endocrinology | Epidemics | Epidemiology | Eyes | Gastroenterology | Georgia Health | Headache | Health | Health Management | Heart | Heart Disease | Insomnia | International Medicine & Public Health | Jobs | Legislation | Marketing | Medical Law | Men | Nurses | Nursing | Occupational Health | Pandemics | Psychiatry | Psychology | Sleep Disorders | Sleep Medicine | Statistics | Study | Vaccines | WHO | Women | Workshops